activity
20242026
collaborators

6 papers

cs.LG2026

How to make the most of your masked language model for protein engineering

Calvin McCarter, Nick Bhattacharya, Sebastian W. Ober +1

A plethora of protein language models have been released in recent years. Yet comparatively little work has addressed how to best sample from them to optimize desired biological pr…

cs.LG2025

Is Sequence Information All You Need for Bayesian Optimization of Antibodies?

Sebastian W. Ober, Calvin McCarter, Aniruddh Raghu +4

Bayesian optimization is a natural candidate for the engineering of antibody therapeutic properties, which is often iterative and expensive. However, finding the optimal choice of…

cs.LG2025

Improved Therapeutic Antibody Reformatting through Multimodal Machine Learning

Jiayi Xin, Aniruddh Raghu, Nick Bhattacharya +3

Modern therapeutic antibody design often involves composing multi-part assemblages of individual functional domains, each of which may be derived from a different source or enginee…

cs.LG2025

Guided Sequence-Structure Generative Modeling for Iterative Antibody Optimization

Aniruddh Raghu, Sebastian Ober, Maxwell Kazman +1

Therapeutic antibody candidates often require extensive engineering to improve key functional and developability properties before clinical development. This can be achieved throug…

stat.ML2024

Bayesian Optimization of Antibodies Informed by a Generative Model of Evolving Sequences

Alan Nawzad Amin, Nate Gruver, Yilun Kuang +6

To build effective therapeutics, biologists iteratively mutate antibody sequences to improve binding and stability. Proposed mutations can be informed by previous measurements or b…

cs.LG2024

Generative Humanization for Therapeutic Antibodies

Cade Gordon, Aniruddh Raghu, Peyton Greenside +1

Antibody therapies have been employed to address some of today's most challenging diseases, but must meet many criteria during drug development before reaching a patient. Humanizat…